Real-world clinical experience with the percutaneous extracorporeal life support system: Results from the German Lifebridge® Registry
Autor: | Maryna Masyuk, Nicolas Langwieser, Konstantinos Sideris, Bernhard Wernly, Assad Haneya, Tobias Graf, Stephan B. Felix, Marcus Franz, Martin J. Hug, Christian Jung, Stefan Sack, Malte Kelm, Georg Fuernau, Peter Abel, Ralf Westenfeld |
---|---|
Rok vydání: | 2019 |
Předmět: |
Male
medicine.medical_specialty Percutaneous Critical Illness medicine.medical_treatment Myocardial Infarction Shock Cardiogenic 030204 cardiovascular system & hematology Extracorporeal Cohort Studies 03 medical and health sciences Extracorporeal Membrane Oxygenation 0302 clinical medicine Germany Internal medicine Humans Medicine Lactic Acid Registries 030212 general & internal medicine Myocardial infarction Cardiopulmonary resuscitation Aged Retrospective Studies business.industry Mortality rate Cardiogenic shock General Medicine Middle Aged medicine.disease Cardiopulmonary Resuscitation Heart Arrest Survival Rate Life support Cohort Emergency medicine Cardiology Female Cardiology and Cardiovascular Medicine business |
Zdroj: | Clinical Research in Cardiology. 109:46-53 |
ISSN: | 1861-0692 1861-0684 |
DOI: | 10.1007/s00392-019-01482-2 |
Popis: | The concept of percutaneous extracorporeal life support (ECLS) is based on immediate cardiovascular stabilization allowing for sufficient end-organ perfusion, thus improving the outcome in patients with circulatory arrest. Lifebridge® (Zoll Medical GmbH, Germany) is a portable ECLS device designed for rapid application due to its automated set-up. A total of 60 tertiary cardiovascular centers were interrogated with regard to application and short-term results after use of Lifebridge ECLS system. Detailed data were collected by standardized case report forms in all centers consented to participate in the study. Demographic and clinical baseline characteristics of the patient population, procedural and follow-up data were recorded and analyzed. In total, 444 patients were analyzed regarding mortality. The detailed study cohort consisted of 112 patients. A total of 80% of the study subjects represented patients post cardiopulmonary resuscitation, 43% were in cardiogenic shock and 50% suffered from acute myocardial infarction. The survival rates were 36% immediately after device implementation and 16% after 30 days. Multivariable analysis revealed that only serum lactate concentration at admission could be proven as independent predictor of patients’ outcome. Patients with lactate concentrations above 10 mmol/L exhibited > 95% mortality (p |
Databáze: | OpenAIRE |
Externí odkaz: |